Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
We hypothesized that adopting a lower rather than a higher threshold for phototherapy discontinuation will be associated with reduced rates of rebound hyperbilirubinemia in term and late preterm neonates with hemolytic disease of newborn. Objectives: The investigators aimed to compare the safety of implementing low-threshold, compared to high- threshold, of TSB for phototherapy interruption in term and late preterm neonates with hemolytic disease of newborn.
Eligibility Criteria
Inclusion Criteria: Healthy term and late-preterm neonates more than or equal 35 weeks gestation with hemolytic disease of newborn will be included. Enrolled infants should have evidence of hemolysis as defined by any of the following criteria: 1. positive DAT and blood group iso-immunization (ABO / RH incompatibility);and /or 2. HGB decline by 2g/dl within 24hour. Exclusion Criteria: * Major congenital abnormalities, * Surgical problems, * Direct hyperbilirubinemia * Sepsis